Institutional investors purchased a net $1.0 million shares of SRPT during the quarter ended March 2014, and now own 69.74% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 2.1 Million shares of Sarepta Therapeutics Inc
EMERALD ADVISERS, INC. Bought 133.6 Thousand shares of Sarepta Therapeutics Inc